Dermata Therapeutics, Inc.DRMANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
-74.18%
↓ 205% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineDecelerating
Average
-24.32%
Historical baseline
| Period | Value |
|---|---|
| 2024 | -74.18% |
| 2023 | 27.45% |
| 2022 | -55.17% |
| 2021 | -41.33% |
| 2020 | -2.71% |
| 2019 | 0.00% |